Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

The Lancet Infectious Diseases

Volumn 20, Issue 10, 2020, Pages 1135-1140

  Carsana, Luca ^a   Sonzogni, Aurelio ^a   Nasr, Ahmed ^a,c   Rossi, Roberta Simona ^a   Pellegrinelli, Alessandro ^a   Zerbi, Pietro ^a,d   Rech, Roberto ^b   Colombo, Riccardo ^b   Antinori, Spinello ^b,d   Corbellino, Mario ^b   Galli, Massimo ^b,d   Catena, Emanuele ^b   Tosoni, Antonella ^a   Gianatti, Andrea ^a   Nebuloni, Manuela ^a,d  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD3 ANTIGEN; CHLORDANE; HOMEOBOX PROTEIN NKX 2.1; KI 67 ANTIGEN; PROTEIN P40; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C;

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; COMORBIDITY; CORONAVIRUS DISEASE 2019; FATALITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE MEMBRANE DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTERSTITIAL PNEUMONIA; ITALY; LUNG ALVEOLUS CELL; LUNG EDEMA; LUNG LESION; LUNG PARENCHYMA; MACROPHAGE; MAIN BRONCHUS; MALE; MULTICENTER STUDY; ORGANIZING PNEUMONIA; PLATELET FIBRIN THROMBOSIS; PNEUMOCYTE HYPERPLASIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SQUAMOUS CELL METAPLASIA; THROMBOSIS; BETACORONAVIRUS; CLINICAL TRIAL; CORONAVIRUS INFECTION; INFLAMMATION; ISOLATION AND PURIFICATION; LUNG; LUNG ALVEOLUS; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PANDEMIC; PATHOLOGY; PULMONARY ARTERY; ULTRASTRUCTURE; VASCULARIZATION; VERY ELDERLY; VIROLOGY; VIRUS PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; HYALINE MEMBRANE DISEASE; INFLAMMATION; ITALY; LUNG; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; PANDEMICS; PNEUMONIA, VIRAL; PULMONARY ALVEOLI; PULMONARY ARTERY; THROMBOSIS;

EID: 85086936769     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(20)30434-5     Document Type: Article

References (20)

1. Grasselli, G, Zangrillo, A, Zanella, A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 323 (2020), 1574–1581.
2. Liu, J, Zheng, X, Tong, Q, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol 92 (2020), 491–494.
3. Hwang, DM, Chamberlain, DW, Poutanen, SM, Low, DE, Asa, SL, Butany, J, Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 18 (2005), 1–10.
4. Alsaad, KO, Hajeer, AH, Al Balwi, M, et al. Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection—clinicopathological and ultrastructural study. Histopathology 72 (2018), 516–524.
5. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
6. Barton, LM, Duval, EJ, Stroberg, E, Ghosh, S, Mukhopadhyay, S, COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol 153 (2020), 725–733.
7. Xu, Z, Shi, L, Wang, Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8 (2020), 420–422.
8. Zhang, H, Zhou, P, Hu, M, et al. Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Inter Med 172 (2020), 629–632.
9. Tian, S, Hu, W, Niu, L, Liu, H, Xu, H, Xiao, SY, Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 15 (2020), 700–704.
10. Fineschi, V, Aprile, A, Aquila, I, et al. Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection—Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures and during autopsy practice. Pathologica, 2020 published online March 26. DOI:10.32074/1591-951X-13-20.
11. Franks, T, Chong, P, Chui, P, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 34 (2003), 743–748.
12. Mandal, RV, Mark, EJ, Kradin, RL, Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol 83 (2007), 327–331.
13. Stertz, S, Reichelt, M, Spiegel, M, et al. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 361 (2007), 304–315.
14. Shieh, WJ, Hsiao, CH, Paddock, CD, et al. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 36 (2005), 303–309.
15. Klok, FA, Kruip, MJHA, van der Meer, NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res, 2020 published online April 10. DOI:10.1016/j.thromres.2020.04.013.
16. Zhou, F, Yu, T, Du, R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395 (2020), 1054–1062.
17. Tang, N, Bai, H, Chen, X, Gong, J, Li, D, Sun, Z, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18 (2020), 1094–1099.
18. Camprubí-Rimblas, M, Tantinyà, N, Bringué, J, Guillamat-Prats, R, Artigas, A, Anticoagulant therapy in acute respiratory distress syndrome. Ann Transl Med, 6, 2018, 36.
19. Kollias, A, Kyriakoulis, KG, Dimakakos, E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol, 2020 published online April 18. DOI:10.1111/bjh.16727.
20. Ogando, NS, Dalebout, TJ, Zevenhoven-Dobbe, JC, et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. bioRxiv, 2020 published online April 20. DOI: 10.1101/2020.04.20.049924 (preprint).